1 month What is Zacks Research’s Forecast for TBPH Q3 Earnings?MarketBeat
Theravance Biopharma, Inc. (NASDAQ:TBPH – Free Report) – Investment analysts at Zacks Research upped their Q3 2025 earnings per share estimates for shares of Theravance Biopharma in a research note issued to investors on Monday, October 21st. Zacks …
Earnings · Nasdaq 100 · Science
X